Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 28, 2019 - Issue 1
Submit an article Journal homepage
465
Views
5
CrossRef citations to date
0
Altmetric
Editorial

Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease

Antoni CaminsDepartament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l’Alimentació, Universitat de Barcelona, Barcelona, Spain;Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain;Institut de Neurociències, Universitat de Barcelona, Barcelona, SpainCorrespondence[email protected]
View further author information
,
Miren EttchetoDepartament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l’Alimentació, Universitat de Barcelona, Barcelona, Spain;Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain;Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain;Departament de Bioquímica i Biotecnologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, Reus, SpainView further author information
,
Oriol BusquetsDepartament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l’Alimentació, Universitat de Barcelona, Barcelona, Spain;Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain;Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain;Departament de Bioquímica i Biotecnologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, Reus, SpainView further author information
,
Patricia R. ManzineDepartament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l’Alimentació, Universitat de Barcelona, Barcelona, Spain;Department of Gerontology, Federal University of São Carlos (UFSCar), São Carlos, BrazilView further author information
,
Rubén Dario Castro-TorresDepartament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l’Alimentació, Universitat de Barcelona, Barcelona, Spain;Departament de Biologia Cel·lular, Fisiologia i Immunologia, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain;Departamento de Biología Celular y Molecular, C.U.C.B.A., Universidad de Guadalajara y División de Neurociencias, Guadalajara, MéxicoView further author information
,
Carlos Beas-ZarateDepartamento de Biología Celular y Molecular, C.U.C.B.A., Universidad de Guadalajara y División de Neurociencias, Guadalajara, MéxicoView further author information
,
Ester VerdaguerBiomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain;Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain;Departament de Biologia Cel·lular, Fisiologia i Immunologia, Facultat de Biologia, Universitat de Barcelona, Barcelona, SpainView further author information
,
Francesc X. SuredaDepartament de Bioquímica i Biotecnologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, Reus, SpainView further author information
,
Monica BullóDepartament de Bioquímica i Biotecnologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, Reus, SpainView further author information
,
Jordi OlloquequiInstituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, ChileView further author information
,
Carme AuladellBiomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain;Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain;Departament de Biologia Cel·lular, Fisiologia i Immunologia, Facultat de Biologia, Universitat de Barcelona, Barcelona, SpainView further author information
&
Jaume FolchBiomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain;Departament de Bioquímica i Biotecnologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, Reus, SpainView further author information
 show all
Pages 93-97 | Received 03 Oct 2018, Accepted 22 Nov 2018, Published online: 01 Dec 2018
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Declaration of interest

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose

Additional information

Funding

This paper was not funded. This work was supported by the Spanish Ministry of Science and Innovation SAF2017-84283-R, PI2016/01 and the European Regional Development Funds. CIBER de Enfermedades Neurodegenrativas (CIBERNED) (Grant CB06/05/2004) is a Project from the Instituto de Salud Carlos III. PR Manzine is supported by grants 2015/26084-1 and 2017/13224-5 from São Paulo Research Foundation (FAPESP), Brazil. RD Castro-Torres received a Postdoctoral Fellowship (No. 298337, CONACYT-MEXICO) in cooperation for consolidating research groups (Doctoral Program in Sciences in Molecular Biology in Medicine, LGAC Molecular Bases of Chronic Degenerative Diseases and its Applications 000091 PNPC, CONACYT-MEXICO).

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,464.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.